RAPT Therapeutics, Inc.: Company Investigated by the Portnoy Law Firm
Investors can the law firm at no cost to learn more about recovering their losses
LOS ANGELES, March 26, 2023 (GLOBE NEWSWIRE) — advises RAPT Therapeutics, Inc. (“RAPT Therapeutics,” or the “Company”) (NASDAQ: RAPT) investors that the firm has initiated